Erythrocin Lactobionate Injection, Powder, Lyophilized, For Solution
Product Images NDC 0409-6482
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Erythrocin Lactobionate (NDC 0409-6482). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Logo (Erythrocin 01a)
Principal Display Panel (500 mg Vial Label)
This text provides instructions for the preparation and use of ERYTHROCIN™ Lactobionate-1.V injection, an intravenous medication with a concentration of 500mg per vial. The medication must be stored in a refrigerator or at room temperature for no more than 24 hours. The initial dilution should be made with sterile water and without preservatives. The text advises users to read the enclosed instructions carefully for information on full dilution guidelines. The resulting initial solution is stable for two weeks, and the concentrated solution contains 50mg of erythromycin activity per mL. The product is distributed by Hospira, Inc.*
Logo (Erythrocin 02a)
Principal Display Panel (500 mg Vial Tray)
The text provides instructions for preparing an intravenous solution using sterile water for injection and Erythromycin Lactobionate - V (an antibiotic medication). The package should be consulted for important information, and the solution should be refrigerated or used within 24 hours if stored at room temperature. The formula is benzyl alcohol-free and is only for intravenous use. The text also includes the equivalent amount of erythromycin and erythromycin activity provided by the medication.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.